[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fiFfMpj45IpNrX7wf2rK8Cy1xX8J3-g50tJ_tArh5RXI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":8,"truncated":9,"activeTrials":10,"phase3Count":11,"totalEnrollment":12,"activePrograms":13,"nonDrugCount":14,"topConditions":15,"upcomingReadouts":37,"phaseBuckets":38,"rows":45},"Texas A&M University",[4,6,7],"Texas A&M University San Antonio","Texas A&M University Kingsville",119,false,26,1,17398,0,111,[16,19,22,25,27,30,32,35],{"name":17,"count":18},"Chronic Obstructive Pulmonary Disease",8,{"name":20,"count":21},"Obesity",7,{"name":23,"count":24},"Healthy",5,{"name":26,"count":24},"Protein Metabolism",{"name":28,"count":29},"Periodontitis",4,{"name":31,"count":29},"Cardiovascular Diseases",{"name":33,"count":34},"Diet Modification",3,{"name":36,"count":34},"Cancer",[],[39,40,41,42,43,44],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[46,74,100,127,152,178,196,221,249],{"intervention":47,"totalTrials":11,"cells":48},"BCG Vaccine",{"EARLY_PHASE1":49,"PHASE1":51,"PHASE2":53,"PHASE3":55,"PHASE4":57,"NA":72},{"trials":50,"activeCount":13},[],{"trials":52,"activeCount":13},[],{"trials":54,"activeCount":13},[],{"trials":56,"activeCount":13},[],{"trials":58,"activeCount":13},[59],{"nctId":60,"briefTitle":61,"status":62,"phases":63,"primaryCompletion":64,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":71},"NCT04348370","BCG Vaccine for Health Care Workers as Defense Against COVID 19","COMPLETED",[43],"2023-04-21","2020-04-20",659,[68,69,70],"Coronavirus","Coronavirus Infection","Coronavirus as the Cause of Diseases Classified Elsewhere",[47],{"trials":73,"activeCount":13},[],{"intervention":75,"totalTrials":11,"cells":76},"Methylprednisolone",{"EARLY_PHASE1":77,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":96,"NA":98},{"trials":78,"activeCount":13},[],{"trials":80,"activeCount":13},[],{"trials":82,"activeCount":13},[],{"trials":84,"activeCount":13},[85],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":91,"start":92,"enrollment":13,"conditions":93,"interventions":95},"NCT03529929","Glucocorticoid Inflammation Paradox in Human Skeletal Muscle","WITHDRAWN",[42],"2020-05-01","2020-12-01","2019-06-01",[94],"Aging",[75],{"trials":97,"activeCount":13},[],{"trials":99,"activeCount":13},[],{"intervention":101,"totalTrials":11,"cells":102},"Ketamine",{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":119,"PHASE3":121,"PHASE4":123,"NA":125},{"trials":104,"activeCount":13},[],{"trials":106,"activeCount":13},[107],{"nctId":108,"briefTitle":109,"status":110,"phases":111,"primaryCompletion":112,"completion":112,"start":113,"enrollment":114,"conditions":115,"interventions":118},"NCT06480201","Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression","SUSPENDED",[40],"2026-12-31","2024-01-01",100,[23,116,117],"Major Depressive Disorder","Treatment Resistant Depression",[101],{"trials":120,"activeCount":13},[],{"trials":122,"activeCount":13},[],{"trials":124,"activeCount":13},[],{"trials":126,"activeCount":13},[],{"intervention":128,"totalTrials":11,"cells":129},"2-DeNT powder",{"EARLY_PHASE1":130,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":150},{"trials":131,"activeCount":13},[132],{"nctId":133,"briefTitle":134,"status":62,"phases":135,"primaryCompletion":136,"completion":136,"start":137,"enrollment":138,"conditions":139,"interventions":141},"NCT02142543","The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer",[39],"2012-12","2012-03",23,[140],"Minor Recurrent Aphthous Stomatitis Lesions",[128],{"trials":143,"activeCount":13},[],{"trials":145,"activeCount":13},[],{"trials":147,"activeCount":13},[],{"trials":149,"activeCount":13},[],{"trials":151,"activeCount":13},[],{"intervention":153,"totalTrials":11,"cells":154},"Pneumovax 23",{"EARLY_PHASE1":155,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":176},{"trials":156,"activeCount":13},[157],{"nctId":158,"briefTitle":159,"status":62,"phases":160,"primaryCompletion":161,"completion":161,"start":162,"enrollment":163,"conditions":164,"interventions":166},"NCT05346302","Persistent Readiness Through Early Prediction Immunization Study",[39],"2022-12-21","2022-02-08",249,[165],"Inflammatory Response",[153,167],"Typhim VI",{"trials":169,"activeCount":13},[],{"trials":171,"activeCount":13},[],{"trials":173,"activeCount":13},[],{"trials":175,"activeCount":13},[],{"trials":177,"activeCount":13},[],{"intervention":167,"totalTrials":11,"cells":179},{"EARLY_PHASE1":180,"PHASE1":186,"PHASE2":188,"PHASE3":190,"PHASE4":192,"NA":194},{"trials":181,"activeCount":13},[182],{"nctId":158,"briefTitle":159,"status":62,"phases":183,"primaryCompletion":161,"completion":161,"start":162,"enrollment":163,"conditions":184,"interventions":185},[39],[165],[153,167],{"trials":187,"activeCount":13},[],{"trials":189,"activeCount":13},[],{"trials":191,"activeCount":13},[],{"trials":193,"activeCount":13},[],{"trials":195,"activeCount":13},[],{"intervention":197,"totalTrials":11,"cells":198},"BSE",{"EARLY_PHASE1":199,"PHASE1":201,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":209},{"trials":200,"activeCount":13},[],{"trials":202,"activeCount":13},[],{"trials":204,"activeCount":13},[],{"trials":206,"activeCount":13},[],{"trials":208,"activeCount":13},[],{"trials":210,"activeCount":13},[211],{"nctId":212,"briefTitle":213,"status":214,"phases":215,"primaryCompletion":216,"completion":216,"start":217,"enrollment":138,"conditions":218,"interventions":220},"NCT01543074","Dietary Histone Deacetylase Inhibitors (HDAC)","TERMINATED",[44],"2013-12","2013-02",[219],"Histone Deacetylase (HDAC) Activity",[197],{"intervention":222,"totalTrials":11,"cells":223},"Mango polyphenolics",{"EARLY_PHASE1":224,"PHASE1":226,"PHASE2":228,"PHASE3":230,"PHASE4":232,"NA":234},{"trials":225,"activeCount":13},[],{"trials":227,"activeCount":13},[],{"trials":229,"activeCount":13},[],{"trials":231,"activeCount":13},[],{"trials":233,"activeCount":13},[],{"trials":235,"activeCount":13},[236],{"nctId":237,"briefTitle":238,"status":62,"phases":239,"primaryCompletion":240,"completion":241,"start":242,"enrollment":243,"conditions":244,"interventions":248},"NCT02227602","Anti-Inflammatory Effects of Mango Polyphenolics in Inflammatory Bowel Disease",[44],"2017-05","2018-03","2014-01",20,[245,246,247],"Intestinal Diseases","Ulcerative Colitis","Crohn Disease",[222],{"intervention":250,"totalTrials":11,"cells":251},"Predefined meal",{"EARLY_PHASE1":252,"PHASE1":254,"PHASE2":256,"PHASE3":258,"PHASE4":260,"NA":262},{"trials":253,"activeCount":13},[],{"trials":255,"activeCount":13},[],{"trials":257,"activeCount":13},[],{"trials":259,"activeCount":13},[],{"trials":261,"activeCount":13},[],{"trials":263,"activeCount":13},[264],{"nctId":265,"briefTitle":266,"status":62,"phases":267,"primaryCompletion":268,"completion":268,"start":269,"enrollment":138,"conditions":270,"interventions":272},"NCT04928872","Macronutrient Distribution and Plasma Metabolites to Model Meals Composition",[],"2020-01-14","2018-06-20",[271],"Glucose Metabolism",[250]]